Table 5.
Literature (n=30 total) |
INSPPIRE/CUSL (n=18 total) |
|||
---|---|---|---|---|
|
|
|||
Outcome | No. of patients/ reported |
(%) | No. of positive/ reported |
(%) |
AIP relapse | 4/23 | (17%) | 4/16 | (25%) |
| ||||
Exocrine pancreatic insufficiency requiring PERT | 1/7 | (14%) | 3/18 | (17%) |
| ||||
Diabetes mellitus | 1/9 | (11%) | 2/18 | (11%) |
AIP, autoimmune pancreatitis; CUSL, Cliniques Universitaires St-Luc; PERT, pancreatic enzyme replacement therapy.